Home / Brands / Central Admixture Pharmacy Services
Central Admixture Pharmacy Services Recalls
347 recalls on record · September 3, 2014 to August 12, 2026 · Drugs
Recalls by year
14
15
23
25
26
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
September 6, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls rocuronium 50 mg/5 mL (10 mg/mL), 5 mL Syringes, Rx only, this drug was repackaged by CAPS Inc, 2200 South 43rd Avenue,
Hazard: Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
September 6, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution del Nido Formula, Total Volume = 1,052.8 mL, EVA Bag, PLASMA-LYTE A 1000 mL, Mannitol 20% 16.3 mL,
Hazard: Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
September 6, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls Cardioplegia Solution, low K, Maintenance 4:1 Plasmalyte, Low Potassium, total volume = 1047 mL, EVA Bag, Rx only, Centr
Hazard: Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
September 6, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls CARDIOPLEGIA SOLUTION, 24 mEq K, Maintenance 8:1, Low Potassium, Total volume = 500 mL, EVA Bag, Rx only, Central Admix
Hazard: Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
September 6, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls CARDIOPLEGIA SOLUTION, HIGH K, Induction 4:1, Plasmalyte/Tromethamine, High Potassium, EVA Bags, total volume = 500 mL,
Hazard: Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
September 6, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls CARDIOPLEGIA SOLUTION, 60 mEq K, Induction 4:1, HIGH POTASSIUM, Total Volume = 830 mL, EVA Bag, RX only, Central Admixtu
Hazard: Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
September 6, 2023DrugsFDA
Central Admixture Pharmacy Services, Inc. recalls CARDIOPLEGIA SOLUTION, 20 mEq K, Maintenance 4:1, Low Potassium, Total Volume = 810 mL, EVA Bag, Rx only, Central Admixt
Hazard: Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls morphine in 0.9% Sodium Chloride, 50 mg/50 mL (1mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL Syringe, Rx only, Central Admixture Pharmacy Services,
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls PHENYLephrine in 0.9 sodium chloride, 400 mcg /10 mL, (40 mcg/mL), 10 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Roa
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls PHENYLephrine in 0.9 sodium chloride, 800 mcg /10 mL, (80 mcg/mL), 10 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Roa
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls rocuronium, 50 mg /5 mL, (10 mg/mL), 5 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Roa
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls midazolam in dextrose 5%, 50 mg /50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 79
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls lidocaine 2%, 100 mg /5 mL, (20 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls ePHEDrine in 0.9% sodium chloride, 50 mg /5 mL, (10 mg/mL), 5 mL Syringe, Rx only, CAPS Inc., Inc., 7935 Dunbrook Road,
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 250 mL, Total fentaNYL 500 mcg/250
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls ketamine in 0.9% sodium chloride, 50 mg/5mL (10mg/mL), 5 mL syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C,
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride, Total Volume = 100 mL, Total FentaNYL 200 mcg/100 m
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total Volume = 250 mL, Total fentaNYL 500 mcg/250
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls morphine in 0.9% sodium chloride, 125 mg/25 mL, (5 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services,
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride, Total Volume = 50 mL, Total fentaNYL 75 mcg/50 mL
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls PHENYLephrine in 0.9% sodium chloride, 1000 mcg/10 mL, (100 mcg/mL), 10 mL syringe, Rx only, Central Admixture Pharmacy
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls morphine in 0.9% sodium chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, I
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls morphine in 0.9% sodium chloride, 1 mg/1 mL, (1 mg/mL), 3 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc.
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 5000 mcg/250 mL, (20 mcg/mL), 250 mL Bag, Rx only, Central Admixture Pharmacy Services
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL syringe, Rx only, Central Admixture Pharmacy Services,
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 2500 mcg/250 mL, (10 mcg/mL), 250 mL bag, Rx only, Central Admixture Pharmacy Services
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in 0.9% sodium chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Servic
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls fentaNYL in 0.9% sodium chloride, 1000 mcg/100 mL, (10 mcg/mL), 100 mL bag, Rx only, CAPS, Central Admixture Pharmacy Se
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles
August 9, 2023DrugsFDA
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL, (0.5 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Serv
Hazard: Lack of assurance of sterility: Lack of validation data for sanitization cycles